Last update 23 Jan 2025
Shandong Hengli Medicine Science & Technology Co., Ltd.

Shandong Hengli Medicine Science & Technology Co., Ltd.

Private Company|
2011|
Shandong Sheng, China
|
www.kbpbiosciences.com

Overview

Tags

Urogenital Diseases
Cardiovascular Diseases
Infectious Diseases
Small molecule drug
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug3
Chemical drugs2
Top 5 TargetCount
MR(Mineralocorticoid receptor)1
LpxC(UDP-3-O-acyl-N-acetylglucosamine deacetylase)1
PDGFR x RET x c-Kit1

Related

13
Drugs associated with Shandong Hengli Medicine Science & Technology Co., Ltd.
Ocedurenone
Target
MR
Mechanism
MR antagonists
Active Org.
Novo Nordisk A/SNovo Nordisk A/S [+2]
Originator Org.
Shandong Hengli Medicine Science & Technology Co., Ltd.Shandong Hengli Medicine Science & Technology Co., Ltd.
Active Indication
Nephrosis [+1]
Inactive Indication
Chronic Kidney Diseases [+4]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
Benapenem
Target
PBPs
Mechanism
PBPs inhibitors [+1]
Active Org.
Shandong Xuanzhu Pharmaceutical Technology Co., Ltd.Shandong Xuanzhu Pharmaceutical Technology Co., Ltd. [+1]
Originator Org.
Shandong Xuanzhu Pharmaceutical Technology Co., Ltd.Shandong Xuanzhu Pharmaceutical Technology Co., Ltd.
Active Indication
Urinary Tract Infections [+3]
Inactive Indication
Bacterial Infections [+5]
Drug Highest PhasePhase 2/3
First Approval Ctry. / Loc.-
First Approval Date-
Zifanocycline
Target
30S subunit
Mechanism
30S subunit inhibitors [+1]
Active Org.
KBP Biosciences USA, Inc.KBP Biosciences USA, Inc.
Originator Org.
Shandong Hengli Medicine Science & Technology Co., Ltd.Shandong Hengli Medicine Science & Technology Co., Ltd.
Active Indication-
Inactive Indication
Bacterial Infections [+5]
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Shandong Hengli Medicine Science & Technology Co., Ltd.
CTR20221758
/ TerminatedPhase 3
一项评估盐皮质激素受体拮抗剂 KBP-5074 在患有中度或重度（3b/4 期）慢性肾脏病（CKD）合并未控制高血压受试者中的有效性和安全性的 3 期、随机、双盲、安慰剂对照、多中心研究
[Translation] A Phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of the mineralocorticoid receptor antagonist KBP-5074 in subjects with moderate or severe (stage 3b/4) chronic kidney disease (CKD) and uncontrolled hypertension
CTR20200018
/ CompletedPhase 1
在中国健康受试者中的桥接试验以及食物影响试验：评价KBP-5074的安全性、耐受性和药代动力学特征
[Translation] Bridging study and food effect study in Chinese healthy subjects: Evaluation of the safety, tolerability and pharmacokinetic characteristics of KBP-5074
100 Clinical Results associated with Shandong Hengli Medicine Science & Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Shandong Hengli Medicine Science & Technology Co., Ltd.
Login to view more data
100 Deals associated with Shandong Hengli Medicine Science & Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shandong Hengli Medicine Science & Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 21 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
4
1
Phase 3 Clinical
Other
8
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Ocedurenone
 ( MR )		Nephrosis
More
Phase 3
KHP-3757
 ( LpxC )		Bacterial Infections
More
Preclinical
KBP-8044
Renal fibrosis
More
Preclinical
KBP-7018
 ( PDGFR x RET x c-Kit )		Fibrosis
More
Preclinical
KBP-8107
Glomerulosclerosis, Focal Segmental
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free